Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
National Cancer Institute (NCI)
University of Washington
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
University of California, Irvine
Incyte Corporation
Merck Sharp & Dohme LLC
Incyte Corporation
University of Southern California
Brigham and Women's Hospital
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
University Hospital, Angers
Thomas Jefferson University
Constellation Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Ohio State University Comprehensive Cancer Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
PharmaEssentia
PharmaEssentia
PharmaEssentia
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
RWTH Aachen University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Italfarmaco
Icahn School of Medicine at Mount Sinai